Core Laboratories Competitors

CLB Stock

USD 13.67 -0.56 -3.94%

CLB runs in the Energy industry (Energy Equipment & Services sector). Core Laboratories NV is grouped alongside Crossamerica Partners, Borr Drilling, Precision Drilling, Granite Ridge, and Nabors Industries for cross-company financial comparison. Gross margin gaps between Core Laboratories and its closest rivals often point to structural cost advantages.

Correlation: Core Laboratories vs Highpeak Energy Overview

Strong inverse diversification

Across the chosen horizon, Core Laboratories and Highpeak Energy show a correlation of -0.24 and fall into the Strong inverse diversification bucket. Lower overlap tends to improve diversification, while higher overlap means both positions carry similar risk.

Moving Against Core Stock

0.38

INTC

Intel Aggressive Push

Pair Corr

Specify up to 10 symbols:

Statistical evidence for mean reversion in Core Laboratories' appears through its tendency to revert after extreme valuations. Under mean reversion theory, Core Laboratories' price extremes are viewed as temporary dislocations that may self-correct. Mean reversion in Core Laboratories' is often observed around historical valuation multiples. Historical data for Core Laboratories shows that extreme valuations have tended to normalize over multi-year periods.

Sentiment

Range

Low	Sentiment	High
10.45	13.73	17.01

Details

Intrinsic

Valuation

Low	Intrinsic	High
9.32	12.60	15.88

Details

Naive

Forecast

Low	Next	High
9.29	12.57	15.84

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
13.59	16.12	18.66

Details

Core Laboratories is positioned within its peer group by benchmarking margins, returns, and multiples. This peer-relative view identifies where Core Laboratories leads, trails, or tracks its competitive set. Benchmarking earnings quality and balance sheet strength against peers provides additional valuation context. Core Laboratories's relative positioning within the peer group reflects its competitive dynamics as currently priced by the market.

Core Laboratories Competition Correlation Matrix

Competition correlation for Core Laboratories NV matters because related securities often respond to the same industry, factor, or macro drivers even when their business stories differ. A reading near +1 usually means prices have moved in tandem, a reading near -1 suggests opposite movement, and a reading near zero points to weaker historical dependence.

	CAPL	BORR	TNP	PDS	GRNT	NBR	VTS	TXO	SOC	HPK
CAPL		-0.5	0.0	-0.12	-0.22	-0.42	0.4	0.01	-0.1	-0.31	CAPL
BORR	-0.5		0.0	0.14	0.17	0.47	-0.11	0.1	-0.14	0.17	BORR
TNP	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	TNP
PDS	-0.12	0.14	0.0		0.48	0.65	-0.38	0.69	0.76	0.87	PDS
GRNT	-0.22	0.17	0.0	0.48		0.63	-0.43	0.51	0.41	0.64	GRNT
NBR	-0.42	0.47	0.0	0.65	0.63		-0.52	0.31	0.55	0.74	NBR
VTS	0.4	-0.11	0.0	-0.38	-0.43	-0.52		-0.03	-0.62	-0.61	VTS
TXO	0.01	0.1	0.0	0.69	0.51	0.31	-0.03		0.44	0.57	TXO
SOC	-0.1	-0.14	0.0	0.76	0.41	0.55	-0.62	0.44		0.83	SOC
HPK	-0.31	0.17	0.0	0.87	0.64	0.74	-0.61	0.57	0.83		HPK
	CAPL	BORR	TNP	PDS	GRNT	NBR	VTS	TXO	SOC	HPK

Please upgrade your account to get full access to Macroaxis premium features

High positive correlations

HPK	+ 0.87	PDS
HPK	+ 0.83	SOC
SOC	+ 0.76	PDS
HPK	+ 0.74	NBR
TXO	+ 0.69	PDS
NBR	+ 0.65	PDS

High negative correlations

SOC	- 0.62	VTS
HPK	- 0.61	VTS
VTS	- 0.52	NBR
BORR	- 0.5	CAPL
VTS	- 0.43	GRNT
NBR	- 0.42	CAPL

Risk-Adjusted Indicators

Headline performance for Core Stock may not fully reflect how the business compares across its competitive set. Risk-adjusted metrics help compare Core Laboratories' efficiency and downside exposure against peers on a like-for-like basis. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CAPL	1.12	-0.05	0.00	1.00	0.00	0.00	2.49	-2.50	7.46
BORR	2.66	0.41	0.13	0.38	2.92	-3.08	6.53	-4.48	16.30
TNP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PDS	1.83	0.24	0.07	-0.70	2.80	-1.78	3.51	-5.23	13.56
GRNT	1.93	0.40	0.11	-0.89	2.85	-1.91	4.26	-5.64	13.80
NBR	2.59	0.67	0.19	2.35	3.06	-2.81	5.59	-5.56	14.41
VTS	1.99	-0.09	0.00	0.33	0.00	0.00	2.78	-4.73	13.90
TXO	1.12	0.08	0.05	-0.13	1.20	-1.30	2.46	-2.07	6.43
SOC	5.00	0.85	0.14	-0.43	5.42	-5.67	8.60	-10.21	48.28
HPK	4.36	0.58	0.10	-0.40	5.05	-4.55	9.62	-8.98	25.29

Core Laboratories Competitive Analysis

A side-by-side look at Core Laboratories, Crossamerica Partners, Borr Drilling, and Tsakos Energy highlights where each stock leads or lags. Core Laboratories enters the comparison at 635.2 M with 526.5 M in revenue. Profitability stands at a 5.53% net margin with return on equity reaching 11.06%. Revenue tilts toward Crossamerica Partners at 3.66 B compared with 526.5 M. On pure scale, Borr Drilling is the bigger entity with market caps of 1.82 B versus 635.2 M. Profit margins tilt toward Tsakos Energy at 21.41% against Core Laboratories at 5.53%.

Better Than Average

Worse Than Peers

View Performance Chart

	CLB	CAPL	BORR	PDS	GRNT	NBR
	3.94 13.67 Core	2.80 21.30 Crossamerica	2.17 5.85 Borr Drilling	1.78 89.93 Precision	1.93 5.59 Granite Ridge	2.93 96.52 Nabors
Market Volatility (90 Days Market Risk)	Stable	Very Low	Slightly Elevated	Very Low	Slightly Elevated	Very Low
Market Performance (90 Days Performance)	Weak	Weak	Mild	Mild	Contained	Balanced
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Low	Minimal	Moderate	Low	Minimal
Current Valuation (Equity Enterprise Value)	Above Model Estimate	Aligned With Model	Aligned With Model	Below Model Estimate	Above Model Estimate	Below Model Estimate
Buy or Sell Analysis (Average Analysts Consensus)	Not Available	Hold	Strong Buy	Strong Buy	Not Available	Hold
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Hold	Hold	Strong Sell	Strong Sell	Hold
Return On Asset TTM	0.0486	0.0463	0.0571	0.0378	0.067	0.0345
Total Asset TTM	596.95 M	964.73 M	3.63 B	2.72 B	1.19 B	4.79 B
Net Income TTM	31.8 M	41.83 M	45 M	1.84 M	24.35 M	248.34 M
Total Debt TTM	206.33 M	907.9 M	2.15 B	790.76 M	17.5 M	2.57 B
Retained Earnings TTM	172.66 M	-25.35 M	-1.23 B	-898.26 M	-17.29 M	-1.84 B
Current Liabilities TTM	120.76 M	74.9 M	206.7 M	175.5 M	N/A	1.01 B
Net Asset	596.95 M	964.73 M	3.63 B	2.72 B	1.19 B	4.79 B
Current Ratio TTM	2.23 X	0.76 X	0.32 X	1.39 X	0.02 X	1.73 X
Price To Book TTM	2.41 X	255.96 X	1.54 X	1.04 X	1.31 X	2.70 X
Current Valuation	792.92 M	1.6 B	3.65 B	1.75 B	1.15 B	3.24 B
Five Year Return	2.66 %	12.09 %	N/A	N/A	N/A	3.99 %
Cash And Equivalents TTM	22.85 M	3.57 M	279 M	51.64 M	172.1 K	940.74 M
Number Of Employees	3.3 K	N/A	2.03 K	5.25 K	6	13.9 K
Shares Outstanding	46.1 M	38.14 M	308.2 M	12.94 M	131.91 M	14.8 M
Debt To Equity TTM	1.29 %	N/A	2.11 %	1.02 %	0.003 %	2.03 %
Annual Yield	0.0028 %	0.10 %	N/A	N/A	0.07 %	N/A
Current Asset TTM	238.55 M	58.12 M	283.67 M	561.95 M	N/A	1.48 B
Trailing Beta	1.0	0.27	1.04	1.37	0.22	1.02
Return On Equity TTM	0.11	0.75	0.0406	0.0019	0.0392	0.22
Profit Margin TTM	0.0553	0.0125	0.0441	0.001	0.0569	0.0738
Number Of Shares Shorted	4.26 M	36.58 K	19.04 M	244.3 K	4.24 M	901.4 K
Price To Sales TTM	1.21 X	0.24 X	1.79 X	0.64 X	1.85 X	0.46 X
Book Value Per Share TTM	5.84 X	-2.68 X	3.98 X	89.91 X	4.62 X	40.62 X
Target Price	16.33	20.0	6.14	96.51	7.3	101.13
Last Dividend Paid	0.03	2.1	N/A	N/A	0.44	N/A
Shares Owned By Institutions	98.57 %	23.75 %	65.51 %	66.70 %	78.69 %	85.15 %
EBITDA TTM	71.12 M	187.81 M	469.8 M	429.61 M	306.84 M	912.67 M
Price To Earnings TTM	101.74 X	6.93 X	-3.16 X	-6.85 X	459.50 X	-2.50 X
Price To Earnings To Growth	1.44 X	-648.25 X	N/A	33.32 X	N/A	2.90 X
Gross Profit TTM	104.54 M	402.71 M	534.6 M	604.05 M	337.85 M	1.27 B
Market Capitalization TTM	635.21 M	795.88 M	1.82 B	1.18 B	792.76 M	1.47 B
Earnings Per Share	0.60 X	1.02 X	0.17 X	-0.76 X	0.18 X	13.67 X
Short Ratio TTM	12.14 X	1.05 X	2.29 X	1.87 X	3.80 X	2.68 X
Operating Margin TTM	0.0162	0.0338	0.26	0.0791	0.21	0.0621
Cash Per Share TTM	0.29 X	0.09 X	1.22 X	3.80 X	N/A	45.15 X
Working Capital TTM	108.65 M	-44.14 M	417.7 M	186.81 M	23.7 M	558.57 M
Shares Owned By Insiders	1.43 %	52.50 %	24.56 %	3.65 %	8.36 %	5.27 %
Revenue TTM	526.52 M	3.66 B	1.02 B	1.84 B	450.31 M	3.18 B
Cash Flow From Operations TTM	37.18 M	91.5 M	251.9 M	411.84 M	296.41 M	693.27 M
Day Typical Price	13.67	21.11	5.82	89.55	5.58	96.81
Accumulation Distribution	N/A	0.0272	0.0154	3719.27	0.0054	19863.02
Market Facilitation Index	N/A	0.58	0.09	0.0	0.03	0.0
Daily Balance Of Power	N/A	1.0	-1.44	-0.50	-3.67	-0.52
Period Momentum Indicator	-0.56	0.58	-0.13	-1.63	-0.11	-2.91
Rate Of Daily Change	0.96	1.03	0.98	0.98	0.98	0.97
Day Median Price	13.67	21.01	5.81	89.37	5.57	96.95
Price Action Indicator	-0.28	0.58	-0.02	-0.25	-0.04	-1.89
Relative Strength Index	36.19	53.7	52.53	47.27	51.3	59.47
Coefficient Of Variation	-733.28	-3,432	806.75	1033.16	667.34	512.51
Mean Deviation	2.36	1.12	2.66	1.83	1.93	2.59
Jensen Alpha	-0.45	-0.05	0.4063	0.2415	0.3976	0.6667
Total Risk Alpha	-0.49	-0.07	0.3816	0.2118	0.3656	0.6338
Sortino Ratio	N/A	N/A	0.1298	0.0733	0.1073	0.1868
Downside Variance	N/A	N/A	9.84	9.68	12.76	12.48
Standard Deviation	3.28	1.49	3.44	2.56	2.69	3.48
Kurtosis	5.81	0.4844	0.0093	2.37	1.36	1.53
Potential Upside	3.6	2.49	6.53	3.51	4.26	5.59
Treynor Ratio	0.7345	0.9988	0.3842	-0.70	-0.89	2.35
Maximum Drawdown	22.57	7.46	16.3	13.56	13.8	14.41
Variance	10.75	2.23	11.87	6.57	7.24	12.13
Market Risk Adjusted Performance	0.7445	1.01	0.3942	-0.69	-0.88	2.36
Risk Adjusted Performance	-0.12	-0.02	0.1267	0.0995	0.1509	0.1953
Skewness	-1.38	-0.28	0.0823	-1.12	-0.80	-0.20
Semi Deviation	N/A	N/A	2.92	2.8	2.85	3.06
Information Ratio	-0.14	-0.04	0.1182	0.089	0.1425	0.1894
Value At Risk	-4.69	-2.50	-4.48	-5.23	-5.64	-5.56
Expected Short fall	N/A	N/A	-3.08	-1.78	-1.91	-2.81
Downside Deviation	N/A	N/A	3.14	3.11	3.57	3.53
Semi Variance	N/A	N/A	8.51	7.81	8.1	9.37

Core Laboratories Competition Peer Performance Charts

How to Analyze Core Laboratories Against Peers

Core Laboratories' peer analysis compares Core Laboratories with related companies to put valuation, quality, and risk metrics in context. This establishes whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:

Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
Check valuation dispersion: Review whether Core Laboratories trades at a premium or discount versus peers and why.
Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
Document the thesis: Record where Core Laboratories leads or lags and what catalysts could close or widen the gap.

Use this as an educational baseline, then validate conclusions with current filings, market conditions, and portfolio objectives.

Peer Comparison Metrics & Methodology

Core Laboratories' capital allocation track record stands out when measured by cumulative returns on acquisitions versus peers. Margin trends that move in opposite directions across peers often foreshadow shifts in competitive positioning. Comparative analysis works best when peers share business drivers, cycle exposure, and capital structure characteristics. For peer comparison, Core Laboratories has a market cap of 635.21 million, P/E of 101.74, profit margin of 5.53%.

Core Laboratories NV figures are aggregated from periodic company reporting and market reference feeds and normalized across reporting formats.

Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board